Citation Impact
Citing Papers
Triple-negative breast cancer molecular subtyping and treatment progress
2020 Standout
Cell cycle proteins as promising targets in cancer therapy
2017 Standout
AURKA contributes to the progression of oral squamous cell carcinoma (OSCC) through modulating epithelial-to-mesenchymal transition (EMT) and apoptosis via the regulation of ROS
2018
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Oxidative Stress in Cancer
2020 Standout
A novel AXL chimeric antigen receptor endows T cells with anti-tumor effects against triple negative breast cancers
2018
Inhibition of CXCL12/CXCR4 axis as a potential targeted therapy of advanced gastric carcinoma
2017
Works of Vikas Sehdev being referenced
The Aurora Kinase A Inhibitor MLN8237 Enhances Cisplatin-Induced Cell Death in Esophageal Adenocarcinoma Cells
2012
HDM2 Regulation by AURKA Promotes Cell Survival in Gastric Cancer
2013
ABL Regulation by AXL Promotes Cisplatin Resistance in Esophageal Cancer
2012
The combination of alisertib, an investigational Aurora kinase A inhibitor, and docetaxel promotes cell death and reduces tumor growth in preclinical cell models of upper gastrointestinal adenocarcinomas
2012
Regulation of CXCR4-Mediated Invasion by DARPP-32 in Gastric Cancer Cells
2012